Orfadin (SWEDISH ORPHAN BIOVITRUM AB (PUBL))
Welcome to the PulseAid listing for the Orfadin drug offered from SWEDISH ORPHAN BIOVITRUM AB (PUBL). This 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC],Hydroxyphenylpyruvate Dioxygenase Inhibitors [MoA],Cytochrome P450 2C9 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | SWEDISH ORPHAN BIOVITRUM AB (PUBL) |
| NON-PROPRIETARY NAME: | Nitisinone |
| SUBSTANCE NAME: | NITISINONE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC],Hydroxyphenylpyruvate Dioxygenase Inhibitors [MoA],Cytochrome P450 2C9 Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2016-07-01 |
| END MARKETING DATE: | 0000-00-00 |
Orfadin HUMAN PRESCRIPTION DRUG Details:
| Item Description | Orfadin from SWEDISH ORPHAN BIOVITRUM AB (PUBL) |
| LABELER NAME: | SWEDISH ORPHAN BIOVITRUM AB (PUBL) |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 2(mg/1) |
| START MARKETING DATE: | 2016-07-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 66658-102_91356576-97d6-4093-a193-0bd1f0a1bcbf |
| PRODUCT NDC: | 66658-102 |
| APPLICATION NUMBER: | NDA021232 |
Other NITISINONE Pharmaceutical Manufacturers / Labelers:
